Russia agrees to produce coronavirus vaccine Sputnik V in India

  • Reuters
Russia agrees to produce coronavirus vaccine Sputnik V in India

MOSCOW, Nov 27 (Reuters) - Russia's sovereign wealth fund and Indian pharmaceutical company Hetero have agreed to produce over 100 million doses per year in India of the Sputnik V vaccine against COVID-19, according to a statement on the Sputnik V Twitter account on Friday.

Hetero and the Russian Direct Investment Fund (RDIF), which has been backing the vaccine and marketing it globally, plan to start production of Sputnik V in India at the beginning of 2021, the statement said.

Phase II-III trials are ongoing in India, the statement said. Drugmaker Dr Reddy's Laboratories Ltd REDY.NS has said it expects late-stage trials to be completed by as early as March 2021.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100
  • Rakesh Prasad @Rakesh Prasad
    Agree , clinical trials , but when? We want now asap.
    Like 0
  • ravi shankar @ravi shankar
    complete bogus.
    Like 0
    • Ashish Gupta @Ashish Gupta
      ok
      Like 0
    • Ashish Gupta @Ashish Gupta
      pls start manufacturing
      Like 0
    • Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

      Error: File type not supported

      Drop an image here or

      100

Related Articles